<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2016//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_160101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">27529215</PMID>
        <DateCreated>
            <Year>2016</Year>
            <Month>8</Month>
            <Day>16</Day>
        </DateCreated>
        <DateRevised>
            <Year>2016</Year>
            <Month>8</Month>
            <Day>16</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1422-0067</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>17</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <MedlineDate>2016</MedlineDate>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of molecular sciences</Title>
                <ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>
            </Journal>
            <ArticleTitle>ST6GALNAC5 Expression Decreases the Interactions between Breast Cancer Cells and the Human Blood-Brain Barrier.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">E1309</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNASSIGNED">The ST6GALNAC5 gene that encodes an £\2,6-sialyltransferase involved in the biosynthesis of £\-series gangliosides, was previously identified as one of the genes that mediate breast cancer metastasis to the brain. We have shown that the expression of ST6GALNAC5 in MDA-MB-231 breast cancer cells resulted in the expression of GD1£\ ganglioside at the cell surface. By using a human blood-brain barrier in vitro model recently developed, consisting in CD34? derived endothelial cells co-cultivated with pericytes, we show that ST6GALNAC5 expression decreased the interactions between the breast cancer cells and the human blood-brain barrier.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Drolez</LastName>
                    <ForeName>Aurore</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Universit? d'Artois (UArtois), EA2465, Laboratoire de la Barri?re H?mato-Enc?phalique (LBHE), Lens F-62300, France. aurore.drolez@univ-artois.fr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author>
                    <LastName>Vandenhaute</LastName>
                    <ForeName>Elodie</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Universit? d'Artois (UArtois), EA2465, Laboratoire de la Barri?re H?mato-Enc?phalique (LBHE), Lens F-62300, France. elodie.vandenhaute@univ-artois.fr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author>
                    <LastName>Delannoy</LastName>
                    <ForeName>Cl?ment Philippe</ForeName>
                    <Initials>CP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Structural and Functional Glycobiology Unit, Unit? Mixte de Recherche (UMR) du Centre National de la Recherche Scientifique (CNRS) 8576, University of Lille, Villeneuve d'Ascq F-59655, France. cl-ment.delannoy@etudiant.univ-lille1.fr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author>
                    <LastName>Dewald</LastName>
                    <ForeName>Justine H?l?ne</ForeName>
                    <Initials>JH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Structural and Functional Glycobiology Unit, Unit? Mixte de Recherche (UMR) du Centre National de la Recherche Scientifique (CNRS) 8576, University of Lille, Villeneuve d'Ascq F-59655, France. justine.dewald@etudiant.univ-lille1.fr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author>
                    <LastName>Gosselet</LastName>
                    <ForeName>Fabien</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Universit? d'Artois (UArtois), EA2465, Laboratoire de la Barri?re H?mato-Enc?phalique (LBHE), Lens F-62300, France. fabien.gosselet@univ-artois.fr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author>
                    <LastName>Cecchelli</LastName>
                    <ForeName>Romeo</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Universit? d'Artois (UArtois), EA2465, Laboratoire de la Barri?re H?mato-Enc?phalique (LBHE), Lens F-62300, France. romeo.cecchelli@univ-artois.fr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author>
                    <LastName>Julien</LastName>
                    <ForeName>Sylvain</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cell Plasticity and Cancer, U908 INSERM, University of Lille, Villeneuve d'Ascq F-59655, France. sylvain.julien@univ-lille1.fr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author>
                    <LastName>Dehouck</LastName>
                    <ForeName>Marie-Pierre</ForeName>
                    <Initials>MP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Universit? d'Artois (UArtois), EA2465, Laboratoire de la Barri?re H?mato-Enc?phalique (LBHE), Lens F-62300, France. mpierre.dehouck@univ-artois.fr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author>
                    <LastName>Delannoy</LastName>
                    <ForeName>Philippe</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Structural and Functional Glycobiology Unit, Unit? Mixte de Recherche (UMR) du Centre National de la Recherche Scientifique (CNRS) 8576, University of Lille, Villeneuve d'Ascq F-59655, France. philippe.delannoy@univ-lille1.fr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author>
                    <LastName>Mysiorek</LastName>
                    <ForeName>Caroline</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Universit? d'Artois (UArtois), EA2465, Laboratoire de la Barri?re H?mato-Enc?phalique (LBHE), Lens F-62300, France. caroline.mysiorek@univ-artois.fr.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType UI="">JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>8</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Int J Mol Sci</MedlineTA>
            <NlmUniqueID>101092791</NlmUniqueID>
            <ISSNLinking>1422-0067</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">GD1£\</Keyword>
            <Keyword MajorTopicYN="N">ST6GALNAC5</Keyword>
            <Keyword MajorTopicYN="N">blood-brain barrier</Keyword>
            <Keyword MajorTopicYN="N">brain metastasis</Keyword>
            <Keyword MajorTopicYN="N">breast cancer</Keyword>
            <Keyword MajorTopicYN="N">gangliosides</Keyword>
            <Keyword MajorTopicYN="N">sialyltransferase</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2016</Year>
                <Month>6</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2016</Year>
                <Month>8</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2016</Year>
                <Month>8</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>8</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>8</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2016</Year>
                <Month>8</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">ijms17081309</ArticleId>
            <ArticleId IdType="doi">10.3390/ijms17081309</ArticleId>
            <ArticleId IdType="pubmed">27529215</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
